|
XPNPEP1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.73300000408483E-08 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.99340000062165E-08 |
| Normal-vs-Stage2 |
4.538300E-02 |
| Normal-vs-Stage3 |
5.701000E-03 |
| Normal-vs-Stage4 |
5.591200E-04 |
| Stage1-vs-Stage2 |
2.297200E-01 |
| Stage1-vs-Stage3 |
9.504000E-02 |
| Stage1-vs-Stage4 |
5.517600E-01 |
| Stage2-vs-Stage3 |
9.759400E-01 |
| Stage2-vs-Stage4 |
5.252400E-01 |
| Stage3-vs-Stage4 |
4.186000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.59519999992841E-07 |
| Normal-vs-AfricanAmerican |
6.352600E-04 |
| Normal-vs-Asian |
2.59909999966723E-07 |
| Caucasian-vs-AfricanAmerican |
2.324600E-01 |
| Caucasian-vs-Asian |
7.787900E-02 |
| AfricanAmerican-vs-Asian |
2.439400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.68540000000351E-05 |
| Normal-vs-Female |
2.02829975037844E-10 |
| Male-vs-Female |
3.463500E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.338500E-02 |
| Normal-vs-Age(41-60Yrs) |
9.66700000049059E-08 |
| Normal-vs-Age(61-80Yrs) |
1.54323000000067E-05 |
| Normal-vs-Age(81-100Yrs) |
5.900200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.347400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.544600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.918000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.657600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.956200E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.957780E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
8.993900E-04 |
| Normal-vs-Grade 2 |
1.78910000037114E-07 |
| Normal-vs-Grade 3 |
3.89840000000197E-05 |
| Normal-vs-Grade 4 |
4.415300E-03 |
| Grade 1-vs-Grade 2 |
3.422000E-02 |
| Grade 1-vs-Grade 3 |
3.304100E-02 |
| Grade 1-vs-Grade 4 |
3.138400E-02 |
| Grade 2-vs-Grade 3 |
5.452800E-01 |
| Grade 2-vs-Grade 4 |
5.701200E-01 |
| Grade 3-vs-Grade 4 |
9.156800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.54899999493807E-08 |
| Normal-vs-ccB subtype |
1.375710E-03 |
| ccA subtype-vs-ccB subtype |
2.223400E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.35720000016271E-07 |
| Normal-vs-N1 |
3.345800E-02 |
| N0-vs-N1 |
5.562800E-01 |
|
|
